AVITA Medical Limited Proposed Redomiciliation to the United States of America - Results of Scheme Meeting

AVITA Medical Limited ACN 058 466 523 (Company) is pleased to announce that shareholders today voted in favour of the scheme of arrangement to effect a redomiciliation of the Company and its subsidiaries (Avita Group) from Australia to the United States of America (Scheme), under which AVITA Therapeutics, Inc. (Avita US), a company incorporated in the State of Delaware in the United States of America, will become the parent company of the Avita Group.

Voting results of Scheme Meeting

In accordance with ASX Listing Rule 3.13.2 and section 251AA(2) of the Corporations Act 2001 (Cth), the Company advises that the resolution to approve the Scheme (set out in the Notice of Scheme Meeting contained in Appendix F of the Scheme Booklet) was passed on a poll by the requisite majorities of shareholders.

The voting results of the Scheme Meeting are attached to this announcement.

Next steps and key dates

The Scheme will not be effective unless and until:

• approval of the Federal Court of Australia (Court) is obtained at the second Court hearing in connection with the Scheme (Second Court Hearing); and
• the Court orders have been lodged with the Australian Securities and Investments Commission (ASIC).

The Second Court Hearing is scheduled to be held at 9.30am (AEST) on Monday, 22 June 2020. If the Court approves the Scheme, the Company expects to lodge the Court orders with ASIC on Tuesday, 23 June 2020.

The expected timetable for implementation of the Scheme is set out below:

Event	Indicative Date
Second Court Hearing	22 June 2020
Effective Date for the Scheme Last day of trading of the Company’s shares on the ASX	23 June 2020
Listing of Avita US on the ASX   Trading of Avita US Chess Depositary Interests (CDIs) commences on the ASX on a deferred settlement basis	24 June 2020
Record Date (for determining the entitlements of shareholders of the Company to Avita US shares or Avita US CDIs)	7.00pm (AEST) on 25 June 2020